Skip Nav Destination
Issues
15 March 2009
-
Cover Image
Cover Image
Alternatively activated M2 macrophages in xenograft model of CNS lymphoma. Fluorescently labeled antibodies were used to show the presence of intratumoral M2 macrophages using anti-CD11b (Alexa Fluor 594, red) and anti-Ym1 (Alexa Fluor 488, green) antibodies. The merged image indicates M2 macrophages exhibiting cytoplasmic expression of Ym-1. For further details, please see Kadoch and coworkers on page 1989 in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
CCR Translations
CCR Practice of Translational Oncology
Molecular Pathways
CCR Special Focus
Review
Human Cancer Biology
Genomic Analysis Using High-Density Single Nucleotide Polymorphism-Based Oligonucleotide Arrays and Multiplex Ligation-Dependent Probe Amplification Provides a Comprehensive Analysis of INI1/SMARCB1 in Malignant Rhabdoid Tumors
Eric M. Jackson; Angela J. Sievert; Xiaowu Gai; Hakon Hakonarson; Alexander R. Judkins; Laura Tooke; Juan Carlos Perin; Hongbo Xie; Tamim H. Shaikh; Jaclyn A. Biegel
Cancer Therapy: Preclinical
Sperm-Derived SPANX-B Is a Clinically Relevant Tumor Antigen That Is Expressed in Human Tumors and Readily Recognized by Human CD4+ and CD8+ T Cells
Giovanni Almanzar; Purevdorj B. Olkhanud; Monica Bodogai; Chiara Dell'Agnola; Dolgor Baatar; Stephen M. Hewitt; Claudio Ghimenton; Mohan K. Tummala; Ashani T. Weeraratna; Keith Sean Hoek; Natalay Kouprina; Vladimir Larionov; Arya Biragyn
Pathologic Correlates of Primary Central Nervous System Lymphoma Defined in an Orthotopic Xenograft Model
Cigall Kadoch; Eduard B. Dinca; Ramona Voicu; Lingjing Chen; Diana Nguyen; Seema Parikh; Juliana Karrim; Marc A. Shuman; Clifford A. Lowell; Patrick A. Treseler; C. David James; James L. Rubenstein
Apo2L/TRAIL Inhibits Tumor Growth and Bone Destruction in a Murine Model of Multiple Myeloma
Agatha Labrinidis; Peter Diamond; Sally Martin; Shelley Hay; Vasilios Liapis; Irene Zinonos; Natalie A. Sims; Gerald J. Atkins; Cristina Vincent; Vladimir Ponomarev; David M. Findlay; Andrew C.W. Zannettino; Andreas Evdokiou
Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab
Alessandra Magnifico; Luisa Albano; Stefano Campaner; Domenico Delia; Fabio Castiglioni; Patrizia Gasparini; Gabriella Sozzi; Enrico Fontanella; Sylvie Menard; Elda Tagliabue
Enhanced Antitumor Efficacy of a DR5-Specific TRAIL Variant over Recombinant Human TRAIL in a Bioluminescent Ovarian Cancer Xenograft Model
Evelien W. Duiker; Elisabeth G.E. de Vries; Devalingam Mahalingam; Gert Jan Meersma; Wytske Boersma-van Ek; Harry Hollema; Marjolijn N. Lub-de Hooge; Go M. van Dam; Robbert H. Cool; Wim J. Quax; Afshin Samali; Ate G.J. van der Zee; Steven de Jong
Imaging, Diagnosis, Prognosis
Cancer Therapy: Clinical
Interaction between BCL2 and Interleukin-10 Gene Polymorphisms Alter Outcomes of Diffuse Large B-Cell Lymphoma following Rituximab Plus CHOP Chemotherapy
Yeon Hee Park; Sang Kyun Sohn; Jong Gwang Kim; Myung-Hoon Lee; Hong Suk Song; Min Kyoung Kim; Joo Seop Jung; Je-Joong Lee; Hyeoung Joon Kim; Dong Hwan Kim
p27Kip1 in Stage III Colon Cancer: Implications for Outcome following Adjuvant Chemotherapy in Cancer and Leukemia Group B Protocol 89803
Monica M. Bertagnolli; Robert S. Warren; Donna Niedzwiecki; Elke Mueller; Carolyn C. Compton; Mark Redston; Margaret Hall; Hejin P. Hahn; Scott D. Jewell; Robert J. Mayer; Richard M. Goldberg; Leonard B. Saltz; Massimo Loda
Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients with Stage IV Malignant Melanoma without Prior Treatment: A Phase IIa Trial
Ian D. Davis; Ben Brady; Richard F. Kefford; Michael Millward; Jonathan Cebon; Birte K. Skrumsager; Ulrik Mouritzen; Lasse Tengbjerg Hansen; Kresten Skak; Dorthe Lundsgaard; Klaus Stensgaard Frederiksen; Paul E.G. Kristjansen; Grant McArthur
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
Jennifer S. Ko; Arnold H. Zea; Brian I. Rini; Joanna L. Ireland; Paul Elson; Peter Cohen; Ali Golshayan; Patricia A. Rayman; Laura Wood; Jorge Garcia; Robert Dreicer; Ronald Bukowski; James H. Finke
A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non–Small Cell Lung Cancer
Robert Mutter; Bo Lu; David P. Carbone; Ildiko Csiki; Luigi Moretti; David H. Johnson; Jason D. Morrow; Alan B. Sandler; Yu Shyr; Fei Ye; Hak Choy
Regulatory T-Cell–Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma
Theo Nicholaou; Lisa M. Ebert; Ian D. Davis; Grant A. McArthur; Heather Jackson; Nektaria Dimopoulos; Bee Tan; Eugene Maraskovsky; Lena Miloradovic; Wendie Hopkins; Linda Pan; Ralph Venhaus; Eric W. Hoffman; Weisan Chen; Jonathan Cebon
Susceptibility and Prevention
Associations between Single Nucleotide Polymorphisms in Double-Stranded DNA Repair Pathway Genes and Familial Breast Cancer
Mary E. Sehl; Lucy R. Langer; Jeanette C. Papp; Lorna Kwan; Joyce L. Seldon; Geovanni Arellano; Jean Reiss; Elaine F. Reed; Sugandha Dandekar; Yael Korin; Janet S. Sinsheimer; Zuo-Feng Zhang; Patricia A. Ganz
Advertisement
